Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Design of bioactive peptides from naturally occurring μ-conotoxin structures.
Stevens M
,
Peigneur S
,
Dyubankova N
,
Lescrinier E
,
Herdewijn P
,
Tytgat J
.
???displayArticle.abstract???
To date, cone snail toxins ("conotoxins") are of great interest in the pursuit of novel subtype-selective modulators of voltage-gated sodium channels (Na(v)s). Na(v)s participate in a wide range of electrophysiological processes. Consequently, their malfunctioning has been associated with numerous diseases. The development of subtype-selective modulators of Na(v)s remains highly important in the treatment of such disorders. In current research, a series of novel, synthetic, and bioactive compounds were designed based on two naturally occurring μ-conotoxins that target Na(v)s. The initial designed peptide contains solely 13 amino acids and was therefore named "Mini peptide." It was derived from the μ-conotoxins KIIIA and BuIIIC. Based on this Mini peptide, 10 analogues were subsequently developed, comprising 12-16 amino acids with two disulfide bridges. Following appropriate folding and mass verification, blocking effects on Na(v)s were investigated. The most promising compound established an IC(50) of 34.1 ± 0.01 nM (R2-Midi on Na(v)1.2). An NMR structure of one of our most promising compounds was determined. Surprisingly, this structure does not reveal an α-helix. We prove that it is possible to design small peptides based on known pharmacophores of μ-conotoxins without losing their potency and selectivity. These data can provide crucial material for further development of conotoxin-based therapeutics.
Buczek,
Structure and sodium channel activity of an excitatory I1-superfamily conotoxin.
2007, Pubmed,
Xenbase
Buczek,
Structure and sodium channel activity of an excitatory I1-superfamily conotoxin.
2007,
Pubmed
,
Xenbase
Bulaj,
Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels.
2005,
Pubmed
Campuzano,
Genetics and cardiac channelopathies.
2010,
Pubmed
Chang,
Predominant interactions between mu-conotoxin Arg-13 and the skeletal muscle Na+ channel localized by mutant cycle analysis.
1998,
Pubmed
,
Xenbase
Chen,
Binding modes of μ-conotoxin to the bacterial sodium channel (NaVAb).
2012,
Pubmed
Choudhary,
Docking of mu-conotoxin GIIIA in the sodium channel outer vestibule.
2007,
Pubmed
,
Xenbase
Clark,
Cyclization of conotoxins to improve their biopharmaceutical properties.
2012,
Pubmed
Cruz,
Conus geographus toxins that discriminate between neuronal and muscle sodium channels.
1985,
Pubmed
Dudley,
A mu-conotoxin-insensitive Na+ channel mutant: possible localization of a binding site at the outer vestibule.
1995,
Pubmed
Ekberg,
Conotoxin modulation of voltage-gated sodium channels.
2008,
Pubmed
Escayg,
Sodium channel SCN1A and epilepsy: mutations and mechanisms.
2010,
Pubmed
Favreau,
A novel µ-conopeptide, CnIIIC, exerts potent and preferential inhibition of NaV1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors.
2012,
Pubmed
,
Xenbase
French,
The tetrodotoxin receptor of voltage-gated sodium channels--perspectives from interactions with micro-conotoxins.
2010,
Pubmed
Fuller,
Oxidative folding of conotoxins sharing an identical disulfide bridging framework.
2005,
Pubmed
Han,
Structurally minimized mu-conotoxin analogues as sodium channel blockers: implications for designing conopeptide-based therapeutics.
2009,
Pubmed
,
Xenbase
Holford,
Pruning nature: Biodiversity-derived discovery of novel sodium channel blocking conotoxins from Conus bullatus.
2009,
Pubmed
,
Xenbase
Hui,
Electrostatic and steric contributions to block of the skeletal muscle sodium channel by mu-conotoxin.
2002,
Pubmed
Jurkat-Rott,
Sodium channelopathies of skeletal muscle result from gain or loss of function.
2010,
Pubmed
Khoo,
Lactam-stabilized helical analogues of the analgesic μ-conotoxin KIIIA.
2011,
Pubmed
,
Xenbase
Khoo,
Structure of the analgesic mu-conotoxin KIIIA and effects on the structure and function of disulfide deletion.
2009,
Pubmed
,
Xenbase
Leipold,
Molecular determinants for the subtype specificity of μ-conotoxin SIIIA targeting neuronal voltage-gated sodium channels.
2011,
Pubmed
Lewis,
Isolation and structure-activity of mu-conotoxin TIIIA, a potent inhibitor of tetrodotoxin-sensitive voltage-gated sodium channels.
2007,
Pubmed
,
Xenbase
Lewis,
Conus venom peptide pharmacology.
2012,
Pubmed
Li,
Clockwise domain arrangement of the sodium channel revealed by (mu)-conotoxin (GIIIA) docking orientation.
2001,
Pubmed
Linge,
Refinement of protein structures in explicit solvent.
2003,
Pubmed
Mantegazza,
Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders.
2010,
Pubmed
McArthur,
Interactions of key charged residues contributing to selective block of neuronal sodium channels by μ-conotoxin KIIIA.
2011,
Pubmed
McArthur,
Multiple, distributed interactions of μ-conotoxin PIIIA associated with broad targeting among voltage-gated sodium channels.
2011,
Pubmed
McArthur,
Orientation of μ-conotoxin PIIIA in a sodium channel vestibule, based on voltage dependence of its binding.
2011,
Pubmed
McIntosh,
A new family of conotoxins that blocks voltage-gated sodium channels.
1995,
Pubmed
Olivera,
Diversity of Conus neuropeptides.
1990,
Pubmed
Piotto,
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions.
1992,
Pubmed
Schroeder,
Neuronally micro-conotoxins from Conus striatus utilize an alpha-helical motif to target mammalian sodium channels.
2008,
Pubmed
,
Xenbase
Schwieters,
The Xplor-NIH NMR molecular structure determination package.
2003,
Pubmed
Shon,
mu-Conotoxin PIIIA, a new peptide for discriminating among tetrodotoxin-sensitive Na channel subtypes.
1998,
Pubmed
Shon,
Purification, characterization, synthesis, and cloning of the lockjaw peptide from Conus purpurascens venom.
1995,
Pubmed
Spence,
Characterization of the neurotoxic constituents of Conus geographus (L) venom.
1977,
Pubmed
Stein,
Torsion-angle molecular dynamics as a new efficient tool for NMR structure calculation.
1997,
Pubmed
Stephan,
The microI skeletal muscle sodium channel: mutation E403Q eliminates sensitivity to tetrodotoxin but not to mu-conotoxins GIIIA and GIIIB.
1994,
Pubmed
,
Xenbase
Stevens,
Neurotoxins and their binding areas on voltage-gated sodium channels.
2011,
Pubmed
Terlau,
Conus venoms: a rich source of novel ion channel-targeted peptides.
2004,
Pubmed
Tietze,
Structurally diverse μ-conotoxin PIIIA isomers block sodium channel NaV 1.4.
2012,
Pubmed
Trivedi,
The role of thiols and disulfides on protein stability.
2009,
Pubmed
Van Der Haegen,
Importance of position 8 in μ-conotoxin KIIIA for voltage-gated sodium channel selectivity.
2011,
Pubmed
,
Xenbase
Walewska,
NMR-based mapping of disulfide bridges in cysteine-rich peptides: application to the mu-conotoxin SxIIIA.
2008,
Pubmed
West,
Mu-conotoxin SmIIIA, a potent inhibitor of tetrodotoxin-resistant sodium channels in amphibian sympathetic and sensory neurons.
2002,
Pubmed
Zhang,
Structural and functional diversities among mu-conotoxins targeting TTX-resistant sodium channels.
2006,
Pubmed
Zhang,
Cooccupancy of the outer vestibule of voltage-gated sodium channels by micro-conotoxin KIIIA and saxitoxin or tetrodotoxin.
2010,
Pubmed
,
Xenbase
Zhang,
Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels.
2007,
Pubmed
,
Xenbase
Zuliani,
Sodium channel blockers as therapeutic target for treating epilepsy: recent updates.
2012,
Pubmed
